FDG-PET/CT in Evaluation and Prognostication of Primary Prostate Lymphoma

被引：9
|
作者：
Hodgson, Richard [2 ]
Huang, Yi-Tung [3 ]
Steinke, Karin [2 ]
Kumar, Aravind S. Ravi [1 ,3 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Nucl Med, Brisbane, Qld 4029, Australia
[2] Royal Brisbane & Womens Hosp, Dept Med Imaging, Brisbane, Qld 4029, Australia
[3] Queensland PET Serv, Brisbane, Qld 4029, Australia
来源：
CLINICAL NUCLEAR MEDICINE | 2010年 / 35卷 / 06期
关键词：
prostate; non-Hodgkin lymphoma; PET/CT; F-18; FDG; prognosis; NON-HODGKINS-LYMPHOMA; CARCINOMA; THERAPY;
D O I：
10.1097/RLU.0b013e3181db4eb7
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 76-year-old man was incidentally diagnosed with prostate lymphoma following transurethral resection of the prostate for prostatism. Staging F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) revealed markedly increased FDG uptake in the prostate, with no evidence of other disease. Following combination chemotherapy, restaging FDG-PET/CT demonstrated a complete metabolic response. The patient subsequently achieved prolonged remission on follow-up. Because of its rarity, FDG-PET in predicting outcome after therapy has not been validated for primary prostate lymphoma. This case highlights the potential of FDG-PET/CT in not only evaluation of disease extent but also prognostication of primary lymphoma of the prostate. Copyright © 2010 by Lippincott Williams & Wilkins.
引用
收藏
页码：418 / 420
页数：3
相关论文
共 50 条
  • [21] Is ceCT necessary beyond FDG-PET/CT for primary staging in Hodgkin lymphoma?
    Kornelia, Kajary
    Zsuzsa, Molnar
    Szabolcs, Szakall, Jr.
    Peter, Molnar
    Zsolt, Lengyel
    ORVOSI HETILAP, 2014, 155 (06) : 226 - 230
  • [22] FDG-PET in lymphoma of the liver: Lesion detection by FDG-PET vs. CT.
    Varavithya, V
    Phongkitkarun, S
    Kazama, T
    Faria, SC
    Mar, M
    Podoloff, DA
    Macapinlac, HA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 83P - 83P
  • [23] 18F]FDG-PET Radiomics Improves Outcome Prognostication in Patients With Primary CNS Lymphoma
    Chen, S.
    Yildirim, O.
    Mauguen, A.
    Grommes, C.
    Schoder, H.
    Mayerhoefer, M. E.
    Krebs, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S467 - S468
  • [24] FDG-PET/CT in Primary Staging of Cholangiocarcinoma
    Sabate-Llobera, A.
    Gracia-Sanchez, L.
    Mestres-Marti, J.
    Puig-Povedano, I.
    Vercher-Conejero, J. L.
    Llinares-Tello, E.
    Rodriguez-Bel, L.
    Robles-Barba, J. J.
    Cortes-Romera, M.
    Llado-Garriga, L.
    Serrano-Pinol, T.
    Ramos-Rubio, E.
    Gamez-Cenzano, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S16 - S17
  • [25] FDG-PET in lymphoma
    Michel Meignan
    Cancer Imaging, 14 (Suppl 1)
  • [26] ROLE OF FDG-PET/CT IN ASSESSMENT OF GASTRIC LYMPHOMA
    Tamam, M. Oner
    Yavuz, H.
    Mulazimoglu, M.
    Edis, N.
    LEUKEMIA RESEARCH, 2017, 61 : S16 - S16
  • [27] Interim FDG-PET/CT for Response Assessment of Lymphoma
    Zeman, Merissa N.
    Akin, Esma A.
    Merryman, Reid W.
    Jacene, Heather A.
    SEMINARS IN NUCLEAR MEDICINE, 2023, 53 (03) : 371 - 388
  • [28] Cat-Scratch Disease A Pitfall for Lymphoma Evaluation by FDG-PET/CT
    Dubreuil, Julien
    Dony, Arthur
    Salles, Gilles
    Traverse-Glehen, Alexandra
    Giammarile, Francesco
    Skanjeti, Andrea
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (02) : 106 - 107
  • [29] FDG-PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy
    Ishimori, T.
    Ishibashi, M.
    Yamada, T.
    Watanabe, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S165 - S165
  • [30] Role of FDG-PET/CT in assessment of gastric lymphoma
    Tamam, M. O.
    Yavuz, H. S.
    Eker, O.
    Mulazimoglu, M.
    Ozpacaci, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S435 - S435
12345